NCT02064673 2026-03-30
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
University of Texas Southwestern Medical Center
Phase 3 Recruiting
Clinical Trials
17 trialsNCT01697566 2025-06-11
An Endometrial Cancer Chemoprevention Study of Metformin
M.D. Anderson Cancer Center
Phase 3 Completed
NCT03769766 2025-06-11
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
University of Texas Southwestern Medical Center
Phase 3 Recruiting
NCT02822573 2023-09-13
Remember
Wake Forest University Health Sciences
Phase 3 Completed
NCT00754845 2023-08-25
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
Canadian Cancer Trials Group
Phase 3 Completed
NCT02772965 2023-04-12
COMBINE
University of North Carolina, Chapel Hill
Phase 3 Completed
NCT05041946 2022-09-29
Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00354432 2021-09-28
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Wake Forest University Health Sciences
Phase 3 Terminated
NCT00206440 2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3 Terminated
NCT00195013 2018-06-06
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Weill Medical College of Cornell University
Phase 3 Completed
NCT00004635 2018-05-22
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00995722 2017-06-02
EPITOME'
University of Miami
Phase 3 Terminated
NCT01468779 2017-03-03
Effect of Probiotics in Patients Undergoing Surgery for Periampullary Neoplasms
Hospital de Clinicas de Porto Alegre
Phase 3 Completed
NCT00152854 2016-03-08
Acetaminophen for Cancer Pain
University Health Network, Toronto
Phase 3 Completed
NCT01788215 2016-01-13
MI-PCOS
University of Rochester
Phase 3 Completed
NCT00735553 2014-08-21
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT00785356 2014-08-21
Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated